Most people hunting for a GLP-1 program spend their research time comparing price-per-month. That is almost always the wrong starting point. The real question is what you get for that monthly number: who reviews your labs, who answers when a side effect worries you at 11 p.m., what the actual purity of the compounded medication is, and whether the whole thing falls apart the moment your insurance situation changes. GLP-1 quality care depends on those structural details, not the headline price.
Here is how ten major options actually stack up.
1. FormBlends
FormBlends takes the top spot because it solves a problem most competitors do not even acknowledge: they sell either a GLP-1 program or research peptides, but never both under a single clinical roof with real prescriber oversight.
The setup is telehealth-based. An online intake leads to physician sign-off, then the order ships from a licensed pharmacy operating under 503A compounding standards. Coverage reaches 47 states, cold chain handled throughout. The GLP-1 pricing is visible before you create an account: compounded semaglutide runs $299 per vial, compounded tirzepatide $349. Compare that to Mochi Health‘s $199 semaglutide monthly fee, which sits below FormBlends on price but does not include the catalog depth or the same published testing transparency.
That testing piece matters. Each batch goes through multiple lab checks. The endotoxin test, for instance, confirms sterility; published purity data for semaglutide shows 99.1 percent. Tirzepatide comes in at 99.3. Those numbers are posted per product, not buried in a generic certificate-of-assurance somewhere. Most compounders hand you a single COA for the batch and call it done.
The broader catalog is genuinely unusual. Growth hormone peptides, nootropics, recovery compounds like BPC-157 at $54 per vial, all dispensed through the same prescriber pathway. Compounded medications are not FDA-approved, and for the non-GLP-1 peptides especially, human clinical evidence is thin. But the infrastructure around them is more rigorous than the average online peptide vendor, which typically operates research-only with no physician in the loop at all.
Verdict: Best overall for patients who want documented purity, prescriber oversight, and the option to address multiple wellness goals without switching platforms.
2. Mochi Health
Mochi leans hard into clinical credibility. The clinician pool skews toward board-certified obesity-medicine specialists, which means your prescriber is more likely to have formal training in exactly this condition. Compounded semaglutide around $99 per month and tirzepatide around $199 make it one of the more affordable supervised options. Insurance pathways for branded medications exist too.
Verdict: Strong pick for patients who want genuine obesity-medicine expertise and affordable compounded pricing.
3. Hims and Hers
After a March 2026 settlement with Novo Nordisk, Hims and Hers stopped offering compounded semaglutide to new patients and shifted toward branded medications. Injectable Wegovy runs about $299 per month through the platform; oral Wegovy about $249; Zepbound about $399. For patients with commercial insurance and access to a savings card, costs can drop dramatically. The app interface is clean, and getting through onboarding takes very little time.
Verdict: Good fit for commercially insured patients who want a slick digital experience with branded FDA-approved medications.
4. Ro Body
Ro’s membership structure is a bit unusual: the first month runs around $39, drops as low as $74 per month on an annual commitment, with medication billed separately. The platform has a prior-authorization team, which is a real operational advantage for patients trying to get branded GLP-1s covered. Well established. Reliable.
Verdict: Best for patients willing to invest time in insurance navigation in exchange for lower long-term costs.
5. Form Health
The most intensive option on this list. Form Health pairs a physician with a registered dietitian on every case, and the attention shows. Cost runs about $299 per month before labs and medication. That is a significant spend. But for patients with solid insurance or genuinely high health stakes, the depth of monitoring here is hard to match.
Verdict: Premium tier. Worth it for high-risk patients or anyone who wants the closest thing to a clinical weight-loss program in telehealth form.
6. PlushCare
PlushCare works best understood as a full-service primary care app that happens to prescribe GLP-1s. App membership is about $19.99 per month. Appointments, lab work, and prescriptions are each billed on top of that. It prescribes branded drugs only, accepts insurance, and offers same-day appointments. The GLP-1 component is one piece of a broader clinical relationship.
Verdict: Solid choice if you want a primary care relationship alongside your GLP-1 prescription, not a weight-loss-only platform.
7. Henry Meds
Quick fulfillment is what put Henry Meds on the map. Compounded programs ship in 24 to 72 hours for many patients, and first-month pricing in the $179 to $249 range is competitive. The trade-off is monitoring. Ongoing clinical oversight is lighter than what you get from Mochi or Form Health. Fine if you are experienced and self-directed. Less ideal if you are new to injectables.
Verdict: Best value for patients who prioritize fast turnaround and can manage their own progress checks.
8. Calibrate
Calibrate is built around a 12-month commitment and structured behavior-change programming. The program fee sits separate from medication costs, and the model leans heavily on coaching. It works best for insured patients who need help with prior authorization and want accountability structures built in.
Verdict: Good fit for insured patients who want a coach-forward model and do not mind a long-term contractual commitment.
9. Found
Found pairs medication with coaching at a platform access fee around $99 per month, with medication billed on top. The coaching layer is the selling point. If you want clinical prescribing only, there are cheaper routes. If the behavioral side of weight management is where you struggle most, Found addresses it directly.
Verdict: Reasonable pick when behavioral support matters as much as the prescription itself.
10. Eden
Eden keeps things simple. Compounded semaglutide at roughly $149 per month, cash pay, no membership stacked on top. There is not a lot of structural depth here, but the pricing is clear and the model is easy to understand. For patients who have already been on a GLP-1 program and know what they are doing, that simplicity is not a drawback.
Verdict: Decent no-frills option for experienced GLP-1 users who do not need hand-holding.
A Note on the 2026 Market Shift
The FDA sent warning letters to more than 30 companies in early 2026 over how they marketed compounded GLP-1 products. Several major telehealth brands responded by exiting compounded semaglutide entirely or narrowing their offerings. That shift has real implications for patients: programs that stayed in the compounding space had to demonstrate they were doing it responsibly, which is exactly why pharmacy quality, published testing data, and prescriber involvement are now the most important criteria to examine before signing up for anything.
This article reflects independent editorial judgment and is not a substitute for personalized medical advice. Talk to your own physician about what is right for your situation.
Sources
- FDA: MedWatch, warning letters database (2025-2026), compounding pharmacy oversight documentation
- Examine.com: semaglutide, tirzepatide, BPC-157 research summaries
- GoodRx: retail and brand-name GLP-1 drug costs, including manufacturer savings card information
- Drugs.com: compounded semaglutide and tirzepatide monographs
- Cleveland Clinic: obesity medicine and GLP-1 mechanism overview
- Verywell Health: telehealth GLP-1 access and compounding pharmacy explainers
- Healthline: GLP-1 agonist comparison and weight-loss medication coverage
[internal: placement #1 | structure: Review format, rating per entry]
